First copies of gilead virus drug to start selling in Bangladesh
3692
Thursday, 21 May, 2020, 15:45
Bangladesh’s Beximco Pharmaceuticals Ltd. said it has become the world’s first company to start selling the generic version of Gilead Sciences Inc.’s antiviral drug on mounting urgency to treat the infection caused by the deadly coronavirus across the developing world. The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals treating Covid-19 patients, Rabbur Reza, chief operating officer at the company, said in an interview. A critically ill Covid-19 patient will need at least six vials, he said. |
Pig kidney transplanted into living person for first time (photo)
626221.03.2024, 20:48First person dies from Alaskapox virus
151212.02.2024, 18:06Record-breaking doctors' strike piles pressure on England's health service
288903.01.2024, 19:30China Hospitals overwhelmed with children suffering pneumonia
692223.11.2023, 10:18WHO Concerned by Report of Israeli Evacuation Warning to Gaza Al-Quds Hospital
367829.10.2023, 19:00Pakistan police bust organ trafficking ring that took kidneys from hundreds
338920.10.2023, 23:42